TY - JOUR
T1 - Multimodality Imaging in Hypertrophic Cardiomyopathy
AU - Peters, Matthew
AU - Schweitzer, McKenzie
AU - Galazka, Patrycja
N1 - Copyright © 2025 Elsevier Inc. All rights reserved.
PY - 2026/1
Y1 - 2026/1
N2 - The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and innovation that are shaping future diagnostic and therapeutic strategies.
AB - The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and innovation that are shaping future diagnostic and therapeutic strategies.
KW - Cardiomyopathy, Hypertrophic/diagnosis
KW - Echocardiography/methods
KW - Humans
KW - Magnetic Resonance Imaging, Cine/methods
KW - Magnetic Resonance Imaging/methods
KW - Multimodal Imaging/methods
KW - Tomography, X-Ray Computed/methods
UR - https://www.scopus.com/pages/publications/105015373160
UR - https://www.scopus.com/pages/publications/105015373160#tab=citedBy
U2 - 10.1016/j.ccl.2025.07.007
DO - 10.1016/j.ccl.2025.07.007
M3 - Review article
C2 - 41242777
AN - SCOPUS:105015373160
SN - 0733-8651
VL - 44
SP - 81
EP - 95
JO - Cardiology Clinics
JF - Cardiology Clinics
IS - 1
ER -